                         SEQUENCE LISTING

<110>  CODEXIS, INC.
       COPE, GREGORY A
 
<120>  METHODS, SYSTEMS, AND SOFTWARE FOR IDENTIFYING BIOMOLECULES WITH 
       INTERACTING COMPONENTS

<130>  CDXSP018WO

<140>  PCT/US2014/013666
<141>  2014-01-29

<150>  61/759,276
<151>  2013-01-31

<150>  61/799,377
<151>  2013-03-15

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic Peptide

<400>  1

Ala Ser Gly Phe 
1               


<210>  2
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic Peptide

<400>  2

Asp Phe Val Ala 
1               


<210>  3
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic Peptide

<400>  3

Lys Leu Gly Ala 
1               


<210>  4
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic Peptide

<400>  4

Asp Ile Val Phe 
1               


<210>  5
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic Peptide

<400>  5

Ala Ile Val Ala 
1               


<210>  6
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic Peptide

<400>  6

Asp Ser Gly Phe 
1               


<210>  7
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic Peptide

<400>  7

Leu Phe Gly Phe 
1               


<210>  8
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic Peptide

<400>  8

Ala Phe Val Ala 
1               


<210>  9
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic Peptide

<400>  9

Leu Ser Gly Phe 
1               


<210>  10
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic Peptide

<400>  10

Asp Leu Val Ala 
1               


<210>  11
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic Peptide

<400>  11

Ile Leu Leu Met Gly Trp Lys Cys Ser Phe 
1               5                   10  


<210>  12
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic Peptide

<400>  12

Val Ala Ile Pro His Asn Arg Thr Ala Tyr 
1               5                   10  


<210>  13
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic Peptide

<400>  13

Val Ala Leu Pro Gly Trp Lys Thr Ser Phe 
1               5                   10  


